On execution, the company described building an integrated commercial organization supported by sales, medical affairs, nurse educators, field reimbursement specialists, and its CrinetiCARE nurse-staffed support program. Chief Commercial Officer Isabel Kalofonos said feedback is centering on efficacy and symptom control, and she noted physicians and patients are responding to the drug’s observed “patterns of action and the symptom controls,” including that it “works in two to four weeks.”Struthers said adop ...